MedPath

Effect of Devdaru Choorna in Prameha (Diabetes Mellitus Type 2)

Phase 2
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2024/08/072285
Lead Sponsor
Dr Samiksha Bhure
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient showing signs and symptoms of Prameha such as –1.Prabhuta Mutrata (polyuria)

2. Avila Mutrata(unclear urine))

3. Ati-sweda (sweating)

4. Daurbalya(weakness)

5. Pipasa(polydipsia)

6. Kshudavriddhi (Polyphagia)

7.Pipilika sancharanvat prachiti

8. Kara dahapada (Burning sensation)

9. Naktamutrata (Nocturnal urination)

and patient already diagnosed with DM type 2 such as –

b. Age 20-70 years.

c. Patient having their Fasting blood glucose level range of 120 - 200 mg/dl.

d. Post prandial blood glucose level range of 170 - 250 mg/dl.

Exclusion Criteria

1.IDDM, Acromegaly, Cushing’s syndrome and Pancreatic disorder.

2. Pregnant and lactating women.

3. Patient with gestational diabetes.

4. Patient suffering from Hepatic dysfunction, Renal dysfunction or Liver cirrhosis.

5. Patient in whom DM is caused as drug induced complication.

6. Those who are under Insulin therapy.

7. Patient with DKA, Lactic acidosis, Sepsis.

8. Patients with acute complications like hyperglycaemic coma, ketoacidosis and infections like gangrene.

9. Patients with K/C/O Nephropathy, Neuropathy and Retinopathy.

10. Patients with conditions like cardiovascular disease, acute MI, Immune compromised disease [HIV].

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in signs and symptoms of Prameha after ingestion of Devdaru choornaTimepoint: 30 days
Secondary Outcome Measures
NameTimeMethod
Where the trial group stands in comparison with control groupTimepoint: 18 months
© Copyright 2025. All Rights Reserved by MedPath